Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.6K
Conserved Binding Sites01:49

Conserved Binding Sites

4.4K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.4K
Ligand Binding Sites02:40

Ligand Binding Sites

13.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.3K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

94
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
94
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

313
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
313

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Why machine learning fails at mass spectrometry for small molecules.

Nature metabolism·2026
Same author

SwitchCraft: A Programmatic Framework for Designing State-Switching Proteins.

ArXiv·2026
Same author

Reply to: Limited evidence of AI superiority in seasonal influenza vaccine strain selection.

Nature medicine·2026
Same author

Protein FID: improved evaluation of protein structure generative models.

Bioinformatics (Oxford, England)·2026
Same author

Bridging the gap: aligning clinical decision support regulation with clinical practice in the era of artificial intelligence.

The Lancet. Digital health·2026
Same author

AssayMatch: Learning To Select Data for Molecular Activity Models.

Journal of chemical information and modeling·2026

相关实验视频

Updated: Sep 15, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K

博尔茨-2:朝着准确而高效的绑定亲和力预测.

Saro Passaro1,2, Gabriele Corso1,2, Jeremy Wohlwend1,2

  • 1MIT CSAIL.

bioRxiv : the preprint server for biology
|July 16, 2025
PubMed
概括

博尔茨-2是一种新的AI模型,准确地预测了生物分子结构和结合亲和力,优于以前的方法. 它为药物发现研究提供了一个计算高效和可控制的方法.

更多相关视频

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.9K

相关实验视频

Last Updated: Sep 15, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.0K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.9K

科学领域:

  • 结构生物学是结构生物学.
  • 计算生物学是一种计算生物学.
  • 生命科学中的人工智能

背景情况:

  • 对生物分子相互作用的准确建模对于理解分子功能和药物开发至关重要.
  • 像AlphaFold3和Boltz-1这样的现有模型在结构预测方面表现出色,但在结合亲和力方面扎.
  • 预测结合亲和力对于评估分子功能和治疗潜力至关重要.

研究的目的:

  • 介绍Boltz-2,一个基础模型,用于增强生物分子结构和结合亲和力预测.
  • 开发一个AI模型,在准确性方面与传统方法竞争,同时显著提高计算效率.
  • 为推进药物发现提供可控制和可扩展的AI框架.

主要方法:

  • 开发了Boltz-2,这是一个结构生物学基础模型,具有先进的可控制功能.
  • 综合实验方法调节,距离约束和多链模板集成用于结构预测.
  • 评估了Boltz-2的性能与已建立的方法相比,例如自由能量扰动 (FEP) 用于结合亲和力预测.

主要成果:

  • 博尔茨-2在生物分子结构和结合亲和力预测方面表现强.
  • 该模型显示了在多个基准测试中与实验数据的强烈相关性.
  • 博尔茨-2实现了与FEP方法相比的结合亲和力预测性能,但在计算上效率超过1000倍.

结论:

  • 博尔茨-2在预测生物分子相互作用方面取得了重大进展,解决了当前人工智能模型的局限性.
  • 该模型的效率和准确性是加速药物发现工作流程的强大工具.
  • 博尔茨-2的代码和权重的公开发布促进了生物机器学习领域的进一步研究和创新.